Cargando…
Practical aspects of chimeric antigen receptor T-cell administration: From commercial to point-of-care manufacturing
Chimeric antigen receptor T-cells targeting the CD19 antigen have achieved impressive results in patients with relapsed/refractory (R/R) B-cell malignancies, leading to their approval in the European Union and other jurisdictions. In Spain, the 100% academic anti-CD19 CART-cell product varnimcabtage...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550897/ https://www.ncbi.nlm.nih.gov/pubmed/36238283 http://dx.doi.org/10.3389/fimmu.2022.1005457 |